| Price | 1,194.00p on 24-03-2026 at 08:18:40 |
|---|---|
| Change | 6.50p 0.55% |
| Buy | 1,194.50p |
| Sell | 1,193.00p |
| Last Trade: | Sell 42.00 at 1,194.00p |
| Day's Volume: | 35,740 |
| Last Close: | 1,187.50p |
| Open: | 1,194.00p |
| ISIN: | GB0009223206 |
| Day's Range | 1,192.00p - 1,198.00p |
| 52wk Range: | 937.80p - 1,441.50p |
| Market Capitalisation: | £10.14b |
| VWAP: | 1,195.29945p |
| Shares in Issue: | 848.99m |
Smith & Nephew (SN.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 42 | 1,194.00p | Automatic Execution |
08:18:38 - 24-Mar-26 |
| Sell* | 144 | 1,196.00p | Automatic Execution |
08:17:50 - 24-Mar-26 |
| Buy* | 518 | 1,196.00p | Automatic Execution |
08:17:43 - 24-Mar-26 |
| Sell* | 52 | 1,196.00p | Automatic Execution |
08:17:43 - 24-Mar-26 |
| Sell* | 86 | 1,196.00p | Automatic Execution |
08:17:43 - 24-Mar-26 |
| Buy* | 365 | 1,197.00p | Automatic Execution |
08:17:39 - 24-Mar-26 |
| Buy* | 540 | 1,197.00p | Automatic Execution |
08:17:39 - 24-Mar-26 |
| Buy* | 602 | 1,196.00p | Automatic Execution |
08:17:34 - 24-Mar-26 |
| Sell* | 59 | 1,196.00p | Automatic Execution |
08:17:34 - 24-Mar-26 |
| Sell* | 85 | 1,196.00p | Automatic Execution |
08:17:34 - 24-Mar-26 |
Smith & Nephew (SN.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 3:08 pm | RNS | Annual Financial Report & Notice of AGM |
| 16th Mar 2026 3:08 pm | RNS | Annual Financial Report & Notice of AGM |
| 10th Mar 2026 2:30 pm | RNS-R | Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention |
| 5th Mar 2026 7:30 am | RNS | Director Declaration |
| 2nd Mar 2026 1:36 pm | RNS | Total Voting Rights |
| 2nd Mar 2026 7:00 am | RNS | Final Results |
| 5th Feb 2026 11:56 am | RNS | Notice of Results |
| 2nd Feb 2026 4:00 pm | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 2nd Feb 2026 3:05 pm | RNS | Total Voting Rights |
| 23rd Jan 2026 2:00 pm | RNS | Director/PDMR Shareholding |